Truist lowered the firm’s price target on Bill (BILL) to $46 from $59 and keeps a Buy rating on the shares as part of a broader research note previewing Q1 results for Payments and Capital Markets names. The setup feels mostly positive as results of the US Banks point to volume upside for the payments group, growth in consumer spending has accelerated so far throughout 2026, and valuations have reset lower following recent underperformance, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BILL:
